For a drug that obeys first-order (linear) kinetics and fits a one-compartment model for elimination:
Rationale:
Its rate of elimination (in mass units of drug/unit time) is proportional to its plasma concentration. This is characteristic of first-order kinetics where the elimination rate depends directly on drug concentration, leading to a constant fraction of the drug being removed per unit time. This relationship underpins linear pharmacokinetics and consistent exponential decay in plasma levels.
B: Following cessation of an intravenous infusion the plasma concentration declines exponentially. This describes drug elimination but does not specifically define first-order kinetics or the proportional relationship between elimination rate and concentration.
C: The half-life is proportional to the dose. Half-life remains constant in first-order kinetics regardless of dose, as elimination depends on concentration, not the amount administered, contradicting this option’s premise.
D: The half-life is unaffected by renal function (i.e. GFR). Renal impairment typically alters drug clearance, affecting half-life; thus, this statement inaccurately assumes constant half-life despite changes in elimination capacity.
Which of the following conditions most likely delayed the oral absorption of acetaminophen in the patient?
Rationale:
The administration of the drug in aqueous solution most likely delayed the oral absorption of acetaminophen. Oral absorption can be slowed by the drug’s formulation, as aqueous solutions may alter dissolution rates or gastric emptying times, influencing the drug's transit and absorption kinetics compared to solid or more lipophilic forms, thereby delaying onset of action.
A: A moderate increase in intestinal peristalsis would typically accelerate drug absorption by enhancing gastrointestinal transit, not delay it, thus it does not explain the slowed oral absorption observed.
B: The presence of strong pain generally does not directly affect the pharmacokinetic process of acetaminophen absorption, making it an unlikely factor for the delayed oral uptake.
D: A large volume of distribution influences drug distribution in tissues after absorption, not the rate of oral absorption, so it does not contribute to delayed acetaminophen uptake.
Cefuroxime:
Rationale:
Cefuroxime has activity against streptococci.
This cephalosporin antibiotic is effective against a broad spectrum of bacteria including streptococci, which are Gram-positive cocci. Its mechanism inhibits cell wall synthesis, targeting susceptible streptococcal species. Clinical use often involves infections caused by these bacteria, demonstrating its relevance and confirmed activity within this group, distinguishing it from antibiotics lacking such coverage.
B: Has no activity against Gram-negative organisms This option is inaccurate since cefuroxime exhibits effectiveness against various Gram-negative bacteria, such as Haemophilus influenzae, expanding its antimicrobial spectrum beyond solely Gram-positive organisms.
C: Plasma concentrations should be monitored to avoid toxicity Routine therapeutic drug monitoring is unnecessary for cefuroxime due to its wide therapeutic index and predictable pharmacokinetics, minimizing risks of toxicity through standard dosing protocols.
D: Is principally renally eliminated Although cefuroxime undergoes renal elimination, this is not its principal characteristic that defines its clinical use or spectrum; its antimicrobial activity against streptococci is more clinically significant.
Which treatments will the nurse anticipate administering to a patient who has been admitted with alcohol toxicity? (Select all that apply.)
Rationale:
Thiamine will be administered to a patient with alcohol toxicity to prevent and treat Wernicke's encephalopathy and other neurological complications caused by chronic alcohol use. This vitamin supports neurological function and metabolism, addressing deficiencies common in alcohol toxicity cases. Administering thiamine is a critical step in stabilizing the patient and preventing long-term brain damage.
A: Naloxone Naloxone is an opioid antagonist used to reverse opioid overdose, not alcohol toxicity, making it irrelevant in treating symptoms caused by excessive alcohol consumption.
C: Intravenous fluids IV fluids may be supportive but are not specific treatments for alcohol toxicity; they primarily address dehydration, not the core neurological and metabolic issues caused by alcohol toxicity.
D: Naltrexone Naltrexone helps reduce alcohol cravings in long-term treatment but is not used in acute alcohol toxicity management and thus is not expected during initial hospital admission.
Azithromycin dosing requires the first day’s dose be twice those of the other 4 days of the prescription. This is considered a loading dose. A loading dose:
Rationale:
A loading dose rapidly achieves drug levels in the therapeutic range. This initial higher dose ensures that the medication quickly reaches effective plasma concentrations, bypassing the slower accumulation that occurs with standard dosing, which is critical for prompt therapeutic effects, especially in infections needing immediate intervention.
B: Requires four to five half-lives to attain This describes the time to reach steady-state, not the purpose of a loading dose, which aims for immediate therapeutic levels rather than gradual accumulation.
C: Is influenced by renal function Renal function affects drug clearance and maintenance dosing, but loading doses primarily focus on quickly reaching therapeutic concentration, not clearance or elimination.
D: Is directly related to the drug circulating to the target tissues Loading dose concerns plasma drug levels rather than distribution specifics; tissue penetration depends on drug properties, not the initial dosing strategy.
Drugs that use CYP 3A4 isoenzymes for metabolism may:
Rationale:
Drugs that use CYP 3A4 isoenzymes for metabolism may both induce and inhibit the metabolism of another drug.
C: CYP 3A4 can be influenced by drugs that either increase enzyme activity, accelerating metabolism, or decrease enzyme activity, slowing metabolism. This dual potential affects drug levels and efficacy, making option C the comprehensive answer encompassing both induction and inhibition mechanisms related to CYP 3A4 metabolism.
A: Induce the metabolism of another drug only describes enhancement of enzyme activity without acknowledging possible inhibition, missing half of the metabolic interaction spectrum involving CYP 3A4.
B: Inhibit the metabolism of another drug solely captures the suppression of enzyme function, neglecting the simultaneous capability of CYP 3A4 to be induced and thus increasing metabolism.
D: Neither A nor B ignores the well-documented effects of CYP 3A4 on drug metabolism, excluding both induction and inhibition, which contradicts established pharmacokinetic principles.
Prazosin can be used for the treatment of hypertension. It acts as
Rationale:
Prazosin acts as an alpha-1 antagonist. This medication selectively blocks alpha-1 adrenergic receptors on vascular smooth muscle, leading to vasodilation and reduced peripheral resistance, which lowers blood pressure. Its role in hypertension management stems from this receptor blockade, distinguishing it from agents targeting beta receptors, making it effective in controlling elevated blood pressure via arterial relaxation.
A: An alpha1-agonist stimulates alpha-1 receptors, causing vasoconstriction and increased blood pressure, which is opposite to prazosin's therapeutic effect in hypertension management.
B: A beta-1 antagonist targets beta-1 adrenergic receptors primarily in the heart, reducing heart rate and contractility, but prazosin does not affect beta receptors.
D: A beta-2 agonist activates beta-2 receptors leading to bronchodilation and vasodilation in specific tissues, unrelated to prazosin’s mechanism of lowering blood pressure.
The pH of a buffer system can be calculated with the
Rationale:
The pH of a buffer system can be calculated with the Henderson - Hasselbalch equation. The Henderson-Hasselbalch equation relates the pH, pKa, and the ratio of conjugate base to acid, making it essential for determining buffer solution pH. It simplifies complex equilibrium expressions into a usable formula for chemists and biologists managing buffer systems in various applications.
A: Noyes - Whitney equation Describes the rate of dissolution of solids in solvents, unrelated to pH or buffer calculations, focusing instead on diffusion and surface area effects in dissolution kinetics.
C: Michaelis - Menten equation Models enzyme kinetics, illustrating reaction rates in enzymatic processes, not involving pH or buffer systems but rather substrate concentration and enzyme activity.
D: Yong equation No recognized or established equation in chemistry for calculating pH or buffer properties, making it irrelevant and nonexistent in standard buffer system analyses.
Triple anti- H-pylori therapy may include all the following drugs except:
Rationale:
Triple anti-H-pylori therapy may include all the following drugs except Famotidine.
Famotidine is not part of the standard triple therapy, which typically combines a proton pump inhibitor (like lansoprazole), clarithromycin (an antibiotic), and either amoxicillin or metronidazole. Famotidine is an H2 receptor antagonist, less effective in increasing gastric pH compared to PPIs, and thus not preferred in standard H. pylori eradication protocols.
A: Ranitidine Ranitidine, another H2 receptor antagonist, has been used in some treatment regimens but is less preferred than PPIs; however, it has been included in some therapy combinations historically.
B: Lansoprazole Lansoprazole is a proton pump inhibitor that effectively suppresses gastric acid, creating an optimal environment for antibiotic efficacy against H. pylori, making it a staple in triple therapy.
D: Clarithromycin Clarithromycin is a macrolide antibiotic essential for targeting H. pylori bacteria directly, included widely in triple therapy due to its potent antibacterial properties.
Enzyme inducers include
Rationale:
Enzyme inducers include Rifampicin. Rifampicin is a potent inducer of cytochrome P450 enzymes, leading to increased metabolism of many drugs. This induction accelerates drug clearance, reducing therapeutic effects. It is widely recognized for its role in enhancing enzymatic activity, thereby altering pharmacokinetic profiles and necessitating dosage adjustments during concurrent administration with other medications.
A: Phenytoin Primarily functions as an anticonvulsant but has comparatively moderate enzyme induction effects, less potent than Rifampicin, and is not the classic example of a strong enzyme inducer.
B: Carbamazepine Acts as an anticonvulsant and mood stabilizer, showing some enzyme induction, yet it lacks the breadth and intensity of Rifampicin’s induction properties in drug metabolism.
C: Phenobarbitone Although it induces enzymes, its induction is slower and less influential on cytochrome P450 compared to Rifampicin, making it a less definitive example of enzyme induction.
Isoniazid:
Rationale:
Isoniazid undergoes acetylation (by N-acetyltransferase) in the liver. This metabolic pathway is significant because it influences the drug’s pharmacokinetics and toxicity profile, with acetylator status affecting plasma concentrations and therapeutic outcomes. Understanding this process is crucial for dosing adjustments and managing side effects in patients receiving isoniazid for tuberculosis treatment.
B: Is used for only the initial two months of the recommended six-month anti-TB regimen in the UK misrepresents isoniazid’s use, as it is administered throughout the full six-month treatment, not just for the initial phase.
C: Is readily absorbed from the gut inaccurately describes isoniazid’s pharmacokinetics since absorption variability exists, and the emphasis is on hepatic metabolism rather than absorption characteristics.
D: Does not diffuse into the CSF contradicts known properties, as isoniazid effectively penetrates the cerebrospinal fluid, making it useful in treating TB meningitis and other CNS infections.
The nurse is describing to a patient the synergistic effects of two of his medications. Which statement by the nurse is correct about synergistic drug effects?
Rationale:
A greater effect is achieved when two drugs are combined. Synergistic effects occur when the combined action of two medications produces a therapeutic outcome greater than the sum of their individual effects. This interaction enhances efficacy, allowing for improved treatment results or reduced dosages, minimizing side effects while maximizing benefits, which is a key concept in pharmacology and patient care.
A: Two drugs have antagonistic effects on each other. This describes drugs that oppose or reduce each other's effects, not producing synergistic enhancement but rather diminishing therapeutic outcomes through competitive or inhibitory interactions.
B: The action of a drug is nullified by another drug. This refers to drug antagonism or neutralization, where one drug cancels out the effect of another, resulting in no therapeutic enhancement or synergistic benefit.
C: One drug acts as an antidote to the side effects of another drug. This involves using a medication to counteract side effects, not creating a combined amplified effect but rather mitigating adverse reactions between drugs.
Nocturnal enuresis is treated with imipramine but not fluoxetine because
Rationale:
Nocturnal enuresis is treated with imipramine but not fluoxetine because imipramine possesses anticholinergic effects but fluoxetine does not. Imipramine’s anticholinergic properties reduce bladder contractility and delay urination reflexes, effectively managing bedwetting. Fluoxetine lacks these effects, making it ineffective for this specific condition despite its antidepressant action.
A: Imipramine induces insomnia while fluoxetine induces sedation does not explain treatment choice, as sleep disturbance profiles are unrelated to enuresis management.
B: Imipramine is safer than fluoxetine overlooks safety profiles; the decision is based on pharmacological effects rather than overall drug safety.
D: All of the above wrongly combines incorrect reasons; only the anticholinergic effect distinguishes imipramine’s role in treating nocturnal enuresis.
The older adult patient has questions about oral drug metabolism. Information on what subject is most important to include in this patient’s teaching plan?
Rationale:
Oral drug metabolism is most importantly influenced by enzyme function. Enzymes in the liver chemically modify drugs, affecting their breakdown and effectiveness. Age-related changes in enzyme activity can alter drug metabolism, making this a crucial topic for older adults to understand how their bodies process medications and the potential need for dosage adjustments or monitoring for side effects.
A: First-pass effect refers to the initial metabolism of a drug in the liver before reaching systemic circulation, but it is less directly relevant to age-related changes in oral drug metabolism than enzyme function.
C: Glomerular filtration rate concerns kidney function and drug excretion rather than the enzymatic processes that primarily govern oral drug metabolism.
D: Motility affects gastrointestinal transit time and absorption, but it does not directly impact the metabolic enzymatic breakdown of orally administered drugs.
Which type of paper best protects a divided hygroscopic powder?
Rationale:
Waxed paper best protects a divided hygroscopic powder. Waxed paper provides a moisture-resistant barrier that prevents the powder from absorbing ambient humidity, maintaining its dryness and stability. Its coating repels water vapor effectively, making it ideal for hygroscopic substances, unlike other paper types that are more permeable to moisture and cannot preserve the powder’s condition adequately over time.
B: Glassine lacks a moisture-resistant coating and is semi-permeable, allowing moisture to penetrate and reach the hygroscopic powder, thus failing to maintain its dryness and protective integrity.
C: White bond paper is porous and absorbs moisture easily, providing insufficient protection for hygroscopic powders that require a moisture barrier to prevent clumping or degradation.
D: Blue bond paper is similar to white bond in texture and permeability, offering minimal resistance to moisture absorption, which makes it unsuitable for protecting hygroscopic powders.
Drug absorption following oral administration:
Rationale:
Drug absorption following oral administration is most commonly through passive diffusion. Passive diffusion allows drugs to move down their concentration gradient without energy expenditure, making it the primary mechanism in the gastrointestinal tract. This process efficiently transports many drugs across cell membranes, especially those that are small and lipophilic, ensuring rapid and effective systemic absorption after oral intake.
B: Occurs predominantly in the colon misrepresents absorption site, as most drug uptake happens in the small intestine due to its larger surface area and richer blood supply, rather than the colon.
C: Is usually complete within 90 minutes overgeneralizes timing, since absorption rates vary widely depending on drug formulation, gastric emptying, and intestinal transit, often exceeding 90 minutes.
D: Non-polar lipid-soluble drugs are absorbed more readily than polar water-soluble drugs incorrectly simplifies absorption, as polar drugs can also be absorbed efficiently via specialized transporters and mechanisms beyond lipid solubility.
In which organ is the majority of cytochrome P450s most highly expressed?
Rationale:
The majority of cytochrome P450s are most highly expressed in the liver. Cytochrome P450 enzymes are primarily involved in metabolizing drugs, toxins, and endogenous compounds, and the liver is the central organ for detoxification and biotransformation, thus expressing these enzymes at the highest levels to efficiently process diverse chemical substances and maintain metabolic homeostasis.
A: Brain Cytochrome P450 enzymes exist in the brain but in much lower concentrations, as the brain's primary function is neural processing, not extensive detoxification or drug metabolism compared to the liver.
C: Lung While lung tissue expresses some cytochrome P450 enzymes for local metabolism, their overall levels are significantly less than in the liver, which serves as the major site for systemic detoxification.
D: Kidney The kidney contributes to excretion and some metabolism, but it expresses fewer cytochrome P450 enzymes relative to the liver, which dominates overall enzymatic activity for drug and toxin processing.
The following inhibit at least one of the hepatic CYP450 isoenzymes:
Rationale:
Grapefruit juice inhibits at least one of the hepatic CYP450 isoenzymes. Grapefruit juice contains compounds that specifically inhibit CYP3A4, a major enzyme involved in drug metabolism in the liver, altering drug bioavailability and potentially causing increased plasma concentrations. This interaction is well-documented and clinically significant, affecting various medications metabolized by this enzyme, thus confirming its inhibitory role.
A: Fluvoxamine primarily inhibits CYP1A2 and CYP2C19 isoenzymes rather than broadly targeting hepatic CYP450 enzymes, so it does not fit the context of general CYP450 inhibition.
C: Digoxin is not metabolized by CYP450 enzymes and does not inhibit these isoenzymes, making it unrelated to hepatic CYP450 enzyme inhibition.
D: Itraconazole inhibits CYP3A4 but mainly in the intestinal wall rather than hepatic CYP450 isoenzymes, thus differing from the hepatic-specific inhibition referenced here.
A 24-year-old primigravid female's water breaks at 39 weeks gestation. Twenty-four hours later, she is having regular contractions 3 min apart. Her labor lasts $8 \mathrm{~h}$. At the hospital, she gives birth to a baby boy, who initially appeared healthy. Within the next $12 \mathrm{~h}$, the baby boy begins to have temperature fluctuations, difficulty breathing, and reduced movements. You suspect neonatal sepsis, so IV gentamicin plus ampicillin is started. Gentamicin and ampicillin are commonly used together because the combined effect is greater than the additive effects of both alone. This increased effectiveness is an example of what principle?
Rationale:
The increased effectiveness of gentamicin and ampicillin used together is an example of synergy. Synergy occurs when two drugs produce a combined effect greater than the sum of their separate effects. This principle enhances antimicrobial activity by targeting different bacterial functions, leading to improved bacterial killing and reduced resistance, making the combination more effective against neonatal sepsis than either drug alone.
A: Agonism refers to a drug activating a receptor to produce a biological response, not the enhanced combined effect of two antibiotics working together. It involves receptor-ligand interaction rather than cooperative drug efficacy.
B: Anergy describes immune system unresponsiveness, not related to drug interactions or combined antibiotic effects. It pertains to immune tolerance, not the enhanced potency of drug combinations.
C: Symbiosis describes a mutually beneficial relationship between organisms, not drug interactions. It does not refer to amplified effects from combined medications but rather biological coexistence between species.
The following anticancer drugs are considered highly emetogenic:
Rationale:
Cisplatin is considered highly emetogenic due to its strong potential to cause severe nausea and vomiting. It directly stimulates the chemoreceptor trigger zone and the gastrointestinal tract, leading to intense emesis. This characteristic makes it a primary target for aggressive antiemetic prophylaxis in chemotherapy regimens. Its emetogenicity surpasses that of many other anticancer agents.
A: Cyclophosphamide generally causes moderate emesis, not reaching the high emetogenic threshold. Its emetic risk is variable but typically less intense compared to agents like cisplatin, warranting moderate antiemetic measures.
B: Methotrexate usually exhibits low to moderate emetogenicity, rarely provoking severe nausea or vomiting. Its emetic impact does not classify it among the highly emetogenic chemotherapy drugs.
C: 5-Fluorouracil is associated with mild to moderate emesis, lacking the potent nausea-inducing effects seen with highly emetogenic drugs like cisplatin. Its emetic potential is comparatively limited.
All the following result in constipation except:
Rationale:
Misoprostol does not result in constipation. Misoprostol primarily causes diarrhea by increasing intestinal motility and secretion, contrasting with agents that slow bowel movements. Its prostaglandin analog activity promotes gastrointestinal smooth muscle contraction, preventing the stagnation associated with constipation, unlike aluminum antacids, ondansetron, and sucralfate, which tend to reduce motility or absorb fluids, leading to constipation.
B: Aluminum containing antacids induce constipation by decreasing gastrointestinal motility and binding phosphate, which reduces bowel movements and hardens stool consistency, contributing to constipation in patients using these medications.
C: Ondansetron causes constipation through its antagonistic effect on serotonin 5-HT3 receptors in the gut, which slows intestinal transit and reduces peristalsis, thereby increasing the likelihood of constipation as a side effect.
D: Sucralfate leads to constipation due to its aluminum content and mucosal coating properties, which can impair normal bowel function and reduce stool frequency, resulting in constipation during treatment.
The following drugs must be avoided in severe renal failure (glomerular filtration rate (GFR) <10 mL/min):
Rationale:
Metformin must be avoided in severe renal failure (GFR <10 mL/min). Metformin accumulates in renal impairment, increasing the risk of lactic acidosis, a potentially fatal complication. Its clearance depends heavily on kidney function, making it unsafe in severe renal failure. Alternative treatments are preferred to prevent this dangerous adverse effect in patients with critically reduced GFR.
A: Prednisolone Prednisolone is metabolized by the liver, not predominantly cleared renally, allowing safer use in severe renal failure without significant accumulation or increased toxicity related to impaired kidney function.
B: Amoxicillin Amoxicillin is renally excreted but dose adjustments can manage its use safely in severe renal failure; it is not absolutely contraindicated, unlike drugs causing severe toxicity or metabolic complications.
C: Bumetanide Bumetanide is a loop diuretic that can be used in renal failure to manage fluid overload; it requires dose adjustment but is not contraindicated, unlike metformin with dangerous systemic effects.
The nurse is administering an intramuscular injection to a 5-year- old child. Choose the correct site the nurse will use.
Rationale:
The nurse will use the deltoid muscle site for administering an intramuscular injection to a 5-year-old child. The deltoid muscle is appropriate for small-volume injections in children over 3 years, offering easy access and fewer risks of damaging major nerves or vessels. It allows effective absorption while ensuring safety and comfort during injection administration.
A: Ventral forearm is unsuitable as it primarily serves for subcutaneous injections and lacks sufficient muscle mass for safe intramuscular injection in children.
B: Dorsogluteal is less preferred in children due to proximity to the sciatic nerve and inconsistent muscle thickness, increasing the risk of injury.
D: Ventrogluteal, though safe, is usually reserved for older children or adults; the deltoid is preferred in young children for smaller injection volumes.
Distribution of drugs to specific tissues
Rationale:
Distribution of drugs to specific tissues depends on the unbound drug concentration gradient between blood and tissue.
This is because only the unbound, free drug molecules can diffuse across membranes and enter tissues. The concentration gradient drives passive diffusion, ensuring that drug distribution reflects the balance between free drug in plasma and tissue, not total drug or protein-bound fractions.
A: Is independent of blood flow to the organ Blood flow significantly influences drug delivery rate, affecting how much drug reaches tissues; ignoring this contradicts pharmacokinetic principles.
B: Is independent of the solubility of the drug in that tissue Tissue solubility affects drug partitioning and retention, influencing distribution; claiming independence overlooks critical physicochemical interactions.
D: Is increased for drugs that are strongly bound to plasma proteins Protein binding limits free drug availability for tissue diffusion; strong binding generally reduces, not increases, tissue distribution.
The renal clearance of insulin is used as a measurement of
Rationale:
The renal clearance of insulin is used as a measurement of Glomerular filtration rate (GFR). Insulin clearance provides an accurate estimate of GFR because insulin is freely filtered by the glomerulus and neither reabsorbed nor secreted by renal tubules, making it an ideal marker to assess kidney filtration efficiency without interference from tubular handling or metabolism.
A: Effective renal blood flow measures the volume of blood delivered to kidneys, not filtration. Insulin clearance specifically reflects filtration capacity, unrelated to total renal perfusion, thus not quantifying blood flow precisely.
B: Rate of renal drug excretion concerns how drugs are eliminated, involving secretion and reabsorption, unlike insulin clearance, which isolates filtration without tubular modification.
C: Intrinsic enzyme activity relates to biochemical reactions within cells, whereas insulin clearance assesses physical filtration in kidneys, so it cannot indicate enzymatic functions.
The following are excreted faster in basic urine
Rationale:
Weak bases are excreted faster in basic urine.
Weak bases become ionized in an alkaline environment, increasing their polarity and reducing reabsorption through renal tubules. This enhanced ionization promotes their elimination via urine, as non-ionized forms more readily cross membranes, whereas ionized forms remain trapped and are efficiently excreted when urine pH is basic.
A: Weak acids remain largely non-ionized in basic urine, reducing their excretion rate since non-ionized molecules reabsorb more easily through renal tubules.
B: Strong acids are almost completely ionized regardless of urine pH, so their excretion rate does not significantly change with urine becoming basic.
D: None of the above fails to recognize that urine pH directly affects ionization and excretion rates, especially for weak bases.
Adverse effects associated with the interferons include:
Rationale:
Adverse effects associated with interferons include lymphopenia. Interferons modulate immune responses and can reduce lymphocyte counts, leading to lymphopenia. This reduction in lymphocytes is a documented hematologic side effect during interferon therapy, reflecting their immunomodulatory impact and potential to cause immunosuppression in patients receiving treatment.
A: Hypocalcaemia is not typically linked to interferon therapy, as calcium imbalances do not commonly arise from their immunomodulatory mechanisms.
B: Inhibition of spermatogenesis is not a recognized adverse effect of interferons, which primarily influence immune cells rather than directly impairing male reproductive function.
C: Renal tubular acidosis is not associated with interferons, as these drugs do not commonly induce significant renal tubular dysfunction or acid-base disturbances.
What term best defines the cimetidine-diazepam interaction where the sedative effect of diazepam increased significantly?
Rationale:
The term that best defines the cimetidine-diazepam interaction with an increased sedative effect is potentiation. Potentiation occurs when one drug enhances the effect of another without having that effect itself. Cimetidine inhibits enzymes metabolizing diazepam, leading to elevated diazepam levels and intensified sedation, exemplifying potentiation rather than a simple additive or synergistic interaction.
A: Synergism describes two drugs producing an effect greater than the sum of their effects, but here cimetidine does not contribute sedative activity, making synergism inappropriate.
C: Additive implies the combined effect equals the sum of each drug’s individual effects, but cimetidine alone lacks sedative properties, so the effect exceeds simple addition.
D: Antagonism involves one drug reducing or blocking another’s effect, whereas cimetidine enhances diazepam’s sedation, ruling out antagonism as a fitting term.
Drugs are metabolized mainly by the liver via Phase I or Phase II reactions. The purpose of both of these types of reactions is to:
Rationale:
Drugs are metabolized mainly by the liver to change drug molecules to a form that an excretory organ can excrete.
Phase I and Phase II reactions chemically modify drugs, often increasing their polarity or water solubility, facilitating elimination by kidneys or bile. These transformations convert lipophilic drugs into hydrophilic metabolites, enhancing their clearance and reducing toxicity, thus ensuring efficient removal from the body through excretory pathways.
A: Inactivate prodrugs before they can be activated by target tissues misrepresents metabolism, as prodrugs require activation rather than inactivation, and liver metabolism typically facilitates activation or detoxification, not premature inactivation.
B: Change the drugs so they can cross plasma membranes incorrectly attributes metabolism a role in membrane permeability, whereas metabolism usually increases polarity, often reducing membrane crossing ability to promote excretion.
D: Make these drugs more ionized and polar to facilitate excretion is partially true but overly specific; metabolism aims broadly at modification for excretion, not solely increasing ionization or polarity.
A 48-year-old-man with end-stage liver disease is hospitalized on the intensive care unit. Review of his blood work reveals elevated liver function tests to five times the normal rate. The patient is receiving multiple intravenous medications. Which of the following medications is likely to be therapeutic for this patient?
Rationale:
Epinephrine is likely to be therapeutic for this patient with end-stage liver disease and elevated liver enzymes. Epinephrine acts as a vasopressor, supporting blood pressure and organ perfusion in critical care settings, especially in cases of shock or hypotension, which are common complications in advanced liver failure, making it essential for ICU management of such patients.
B: Erythromycin is not suitable as it can cause hepatotoxicity and worsen liver function, especially in patients with liver impairment. It may increase liver enzyme levels, exacerbating the patient’s pre-existing hepatic condition.
C: Nifedipine primarily treats hypertension and angina but does not address critical circulatory support needed in liver failure with elevated enzymes. It lacks immediate therapeutic relevance in acute ICU settings.
D: Rifampin is hepatotoxic and induces liver enzymes, potentially aggravating liver injury. It is contraindicated in severe liver disease due to its metabolism and risk of worsening hepatic function.